Business Description
Orient Pharma Co Ltd
SIC : 111
ISIN : TW0004166004
Description
Orient Pharma Co Ltd develops and manufactures pharmaceuticals. The company uses its platform technologies for the development of specialty pharmaceutical products and is capable of manufacturing products under cGMP. It provides drugs for treating Alzheimer's disease, psychostimulants, and treating Parkinson's disease.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | 2.19 | |||||
| Interest Coverage | 10.82 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.89 | |||||
| Beneish M-Score | -1.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17.9 | |||||
| 3-Year FCF Growth Rate | 15.5 | |||||
| 3-Year Book Growth Rate | 4.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.39 | |||||
| 9-Day RSI | 48.1 | |||||
| 14-Day RSI | 52.01 | |||||
| 6-1 Month Momentum % | 27.49 | |||||
| 12-1 Month Momentum % | 71.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | |||||
| Quick Ratio | 0.83 | |||||
| Cash Ratio | 0.32 | |||||
| Days Inventory | 179.25 | |||||
| Days Sales Outstanding | 59.5 | |||||
| Days Payable | 38.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6 | |||||
| Shareholder Yield % | -0.88 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.92 | |||||
| Operating Margin % | 14.52 | |||||
| Net Margin % | 11.18 | |||||
| FCF Margin % | 13.59 | |||||
| ROE % | 7.02 | |||||
| ROA % | 4.62 | |||||
| ROIC % | 5.19 | |||||
| ROC (Joel Greenblatt) % | 13.17 | |||||
| ROCE % | 8.19 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 68.63 | |||||
| PE Ratio without NRI | 64.13 | |||||
| PS Ratio | 7.59 | |||||
| PB Ratio | 4.57 | |||||
| Price-to-Tangible-Book | 6.38 | |||||
| Price-to-Free-Cash-Flow | 55.94 | |||||
| Price-to-Operating-Cash-Flow | 47.44 | |||||
| EV-to-EBIT | 51.78 | |||||
| EV-to-EBITDA | 28.36 | |||||
| EV-to-Revenue | 8.04 | |||||
| EV-to-FCF | 58.62 | |||||
| Price-to-Median-PS-Value | 0.93 | |||||
| Price-to-Graham-Number | 4.27 | |||||
| Earnings Yield (Greenblatt) % | 1.93 | |||||
| FCF Yield % | 1.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Orient Pharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,065.657 | ||
| EPS (TTM) (NT$) | 0.529 | ||
| Beta | 0.23 | ||
| Volatility % | 19.04 | ||
| 14-Day RSI | 52.01 | ||
| 14-Day ATR (NT$) | 2.507138 | ||
| 20-Day SMA (NT$) | 37.7875 | ||
| 12-1 Month Momentum % | 71.89 | ||
| 52-Week Range (NT$) | 19.45 - 50.7 | ||
| Shares Outstanding (Mil) | 223.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Orient Pharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Orient Pharma Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Orient Pharma Co Ltd Frequently Asked Questions
What is Orient Pharma Co Ltd(ROCO:4166)'s stock price today?
The current price of ROCO:4166 is NT$36.30. The 52 week high of ROCO:4166 is NT$50.70 and 52 week low is NT$19.45.
When is next earnings date of Orient Pharma Co Ltd(ROCO:4166)?
The next earnings date of Orient Pharma Co Ltd(ROCO:4166) is .
Does Orient Pharma Co Ltd(ROCO:4166) pay dividends? If so, how much?
Orient Pharma Co Ltd(ROCO:4166) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers